Annotation Detail

Information
Associated Genes
PTEN
Associated Variants
PTEN DELETION ( ENST00000371953.8 )
PTEN DELETION ( ENST00000371953.8 )
Associated Disease
endometrial cancer
Source Database
CIViC Evidence
Description
A panel of 24 endometroid endometrial cancer (EEC) cell lines was characterized for mutations and 18 cell lines were found to have mutations in PTEN or absence of expression. Cell lines were assessed for sensitivity to mTORC1 allosteric inhibitor temsirolimus, and it was reported that PTEN loss had significant association with temsirolimus sensitivity. .
Variant Origin
somatic
Variant Origin
Somatic
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/1614
Gene URL
https://civic.genome.wustl.edu/links/genes/41
Variant URL
https://civic.genome.wustl.edu/links/variants/214
Rating
3
Evidence Type
Predictive
Disease
Endometrial Cancer
Evidence Direction
Supports
Drug
Temsirolimus
Evidence Level
D
Clinical Significance
Sensitivity/Response
Pubmed
23674493
Drugs
Drug NameSensitivitySupported
TemsirolimusSensitivitytrue